Cargando…

Targeting the inflammasome in Parkinson’s disease

Parkinson’s disease (PD) is one of the most common neurodegenerative diseases in which neuroinflammation plays pivotal roles. An important mechanism of neuroinflammation is the NLRP3 inflammasome activation that has been implicated in PD pathogenesis. In this perspective, we will discuss the relatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Qi, Ng, Wei Lun, Goh, Suh Yee, Gulam, Muhammad Yaaseen, Wang, Lin-Fa, Tan, Eng-King, Ahn, Matae, Chao, Yin-Xia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596750/ https://www.ncbi.nlm.nih.gov/pubmed/36313019 http://dx.doi.org/10.3389/fnagi.2022.957705

Ejemplares similares

Gut–Brain Axis: Potential Factors Involved in the Pathogenesis of Parkinson's Disease
por: Chao, Yin-Xia, et al.
Publicado: (2020)

Corrigendum: Gut–Brain Axis: Potential Factors Involved in the Pathogenesis of Parkinson's Disease
por: Chao, Yin-Xia, et al.
Publicado: (2020)

Parkinson’s Disease-Specific Autoantibodies against the Neuroprotective Co-Chaperone STIP1
por: Tan, Jolene Su Yi, et al.
Publicado: (2022)

Role of MicroRNAs in Parkinson’s Disease
por: Goh, Suh Yee, et al.
Publicado: (2019)

Unique Loss of the PYHIN Gene Family in Bats Amongst Mammals: Implications for Inflammasome Sensing
por: Ahn, Matae, et al.
Publicado: (2016)

MR1-Restricted T Cells with MAIT-like Characteristics Are Functionally Conserved in the Pteropid Bat Pteropus alecto
por: Leeansyah, Edwin, et al.
Publicado: (2020)

Translation from bats to humans beyond infectious diseases
por: Ahn, Matae, et al.
Publicado: (2021)

New Insights into Immune-Mediated Mechanisms in Parkinson’s Disease
por: Tan, Jolene Su Yi, et al.
Publicado: (2020)

Historical Perspective: Models of Parkinson’s Disease
por: Chia, Shyh Jenn, et al.
Publicado: (2020)

Increased Activation of Default Mode Network in Early Parkinson’s With Excessive Daytime Sleepiness
por: Ooi, Leon Qi Rong, et al.
Publicado: (2019)

Corrigendum: Increased Activation of Default Mode Network in Early Parkinson's With Excessive Daytime Sleepiness
por: Ooi, Leon Qi Rong, et al.
Publicado: (2020)

Molecular targets for modulating the protein translation vital to proteostasis and neuron degeneration in Parkinson’s disease
por: Zhou, Zhi Dong, et al.
Publicado: (2019)

Serial deep gray nuclear DTI changes in Parkinson’s disease over twelve years
por: Shih, Yao-Chia, et al.
Publicado: (2023)

Targeting NLRP3 Inflammasome in the Treatment of CNS Diseases
por: Shao, Bo-Zong, et al.
Publicado: (2018)

Current Status of Stem Cell-Derived Therapies for Parkinson’s Disease: From Cell Assessment and Imaging Modalities to Clinical Trials
por: Jang, Se Eun, et al.
Publicado: (2020)

Interaction between autophagy and the NLRP3 inflammasome in Alzheimer’s and Parkinson’s disease
por: Lu, Ranran, et al.
Publicado: (2022)

Parkinson’s disease following COVID-19: causal link or chance occurrence?
por: Li, Wei-Shan, et al.
Publicado: (2020)

Targeting LRRK2 in Parkinson’s disease
por: Xiao, Bin, et al.
Publicado: (2022)

Evidence of Inflammatory System Involvement in Parkinson's Disease
por: Chao, Yinxia, et al.
Publicado: (2014)

Familial Parkinson's Disease/Parkinsonism
por: Tomiyama, Hiroyuki, et al.
Publicado: (2015)

Case-control study of hypertension and Parkinson’s disease
por: Ng, Yuen-Fann, et al.
Publicado: (2021)

Inflammasome Activation in Parkinson’s Disease
por: Jewell, Shannon, et al.
Publicado: (2022)

Induced pluripotent stem cells in Parkinson's disease: scientific and clinical challenges
por: Xiao, Bin, et al.
Publicado: (2016)

Key Mechanisms and Potential Targets of the NLRP3 Inflammasome in Neurodegenerative Diseases
por: Guan, Yadi, et al.
Publicado: (2020)

Combination therapy using GDNF and cell transplant in Parkinson’s disease
por: Xiao, Bin, et al.
Publicado: (2022)

MDPD: an integrated genetic information resource for Parkinson's disease
por: Tang, Suisheng, et al.
Publicado: (2009)

Immunotherapy trials in Parkinson’s disease: challenges
por: Xiao, Bin, et al.
Publicado: (2023)

New Perspectives on Roles of Alpha-Synuclein in Parkinson’s Disease
por: Zhang, Guoxin, et al.
Publicado: (2018)

Inflammasome Proteins As Biomarkers of Multiple Sclerosis
por: Keane, Robert W., et al.
Publicado: (2018)

Inhibition of NLRP3 Inflammasome: A Prospective Target for the Treatment of Ischemic Stroke
por: Feng, Ya-Shuo, et al.
Publicado: (2020)

NLRP3 Inflammasome-Dependent Increases in High Mobility Group Box 1 Involved in the Cognitive Dysfunction Caused by Tau-Overexpression
por: Zhao, Yan, et al.
Publicado: (2021)

Cell replacement for Parkinson’s disease: advances and challenges
por: Xiao, Bin, et al.
Publicado: (2023)

Bats and Coronaviruses in the Context of COVID-19
por: Wang, Linfa, et al.
Publicado: (2021)

Gender Differences of NLRP1 Inflammasome in Mouse Model of Alzheimer's Disease
por: Zhang, Jinghang, et al.
Publicado: (2020)

Inflammasome: a new trigger of Alzheimer's disease
por: Saco, Tara, et al.
Publicado: (2014)

Dl-3-n-Butylphthalide Rescues Dopaminergic Neurons in Parkinson’s Disease Models by Inhibiting the NLRP3 Inflammasome and Ameliorating Mitochondrial Impairment
por: Que, Rongfang, et al.
Publicado: (2021)

Patient-Derived Induced Pluripotent Stem Cells and Organoids for Modeling Alpha Synuclein Propagation in Parkinson's Disease
por: Koh, Yong Hui, et al.
Publicado: (2018)

Crosstalk Between the NLRP3 Inflammasome/ASC Speck and Amyloid Protein Aggregates Drives Disease Progression in Alzheimer’s and Parkinson’s Disease
por: Hulse, Jonathan, et al.
Publicado: (2022)

Flow Cytometry-Based Assessment of Mitophagy Using MitoTracker
por: Xiao, Bin, et al.
Publicado: (2016)

Enhanced Autolysosomal Function Ameliorates the Inflammatory Response Mediated by the NLRP3 Inflammasome in Alzheimer’s Disease
por: Zhou, Wen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bbs3gcbrp0m2o0u443ep9c8l3j